These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25743172)

  • 21. Familial hypercholesterolaemia: PCSK9 inhibitors are coming.
    Santos RD; Watts GF
    Lancet; 2015 Jan; 385(9965):307-10. PubMed ID: 25282517
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterozygotic familial hypercholesterolemia: argument for early treatment].
    Rosenburg D
    Arch Pediatr; 2004 Nov; 11(11):1410-1. PubMed ID: 15595191
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of PCSK9 in familial hypercholesterolaemia.
    Sijbrands EJ
    Lancet; 2012 Jul; 380(9836):6-7. PubMed ID: 22633823
    [No Abstract]   [Full Text] [Related]  

  • 24. When should patients with heterozygous familial hypercholesterolemia be treated?
    Rifkind BM; Schucker B; Gordon DJ
    JAMA; 1999 Jan; 281(2):180-1. PubMed ID: 9917123
    [No Abstract]   [Full Text] [Related]  

  • 25. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 26. Familial hypercholesterolemia: a decade of progress.
    Gidding SS
    J Pediatr; 2010 Feb; 156(2):176-7. PubMed ID: 20105635
    [No Abstract]   [Full Text] [Related]  

  • 27. [Familial hypercholesterolemia].
    Widhalm K
    Dtsch Med Wochenschr; 2000 Jan; 125(4):99. PubMed ID: 10733301
    [No Abstract]   [Full Text] [Related]  

  • 28. Improving the Monitoring and Care of Patients With Familial Hypercholesterolemia.
    Hegele RA
    J Am Coll Cardiol; 2016 Mar; 67(11):1286-8. PubMed ID: 26988948
    [No Abstract]   [Full Text] [Related]  

  • 29. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 30. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 31. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel pharmacological treatments for children and adolescents with heterozygous familial hypercholesterolemia.
    Wiegman A; Hutten BA
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):919-921. PubMed ID: 28756723
    [No Abstract]   [Full Text] [Related]  

  • 33. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 34. A First-in-Class Drug, Lomitapide, Tailored to Patients with Homozygous Familial Hypercholesterolemia is Just about Meeting with Good News to Them.
    Yoshida H
    J Atheroscler Thromb; 2017 Apr; 24(4):390-392. PubMed ID: 28239069
    [No Abstract]   [Full Text] [Related]  

  • 35. Beneficial effect of simvastatin in patients with drug resistant familial hypercholesterolaemia.
    Lewis-Barned NJ; Ball MJ
    N Z Med J; 1992 Jul; 105(938):284-6. PubMed ID: 1495661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic principles of food related problems--familial hypercholesterolaemia].
    Floré M; Robberecht N; Hermans H
    J Pharm Belg; 2012 Mar; (1):18-21. PubMed ID: 22536679
    [No Abstract]   [Full Text] [Related]  

  • 37. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 38. [Familial hypercholesterolemia: treatable receptor disease].
    Kovanen PT; Tikkanen MJ; Pyörälä K
    Duodecim; 1992; 108(15):1305-17. PubMed ID: 1366090
    [No Abstract]   [Full Text] [Related]  

  • 39. Rescue therapy with PCSK9 inhibitors for patients with delayed diagnosis of heterozygous familial hypercholesterolemia: Redressing the balance of missed opportunities.
    Vuorio A; Watts GF; Kovanen PT
    J Clin Lipidol; 2016; 10(5):1278-9. PubMed ID: 27678448
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lowering of the lipoproteins in type IIa hyperlipoproteinemia by means of bezafibrate. Comparison with clofibrate].
    Mertz DP; Suermann I; Loewer H
    MMW Munch Med Wochenschr; 1979 Oct; 121(40):1295-6. PubMed ID: 226879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.